| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07% | 3 | Zacks | ||
| Mo | Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday | 1 | Benzinga.com | ||
| 22.05. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.05. | The Oncology Institute GAAP EPS of -$0.02 beats by $0.07, revenue of $147.4M beats by $5.42M | 1 | Seeking Alpha | ||
| 07.05. | Oncology Institute, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.04. | Here's What Powered The Oncology Institute's (TOI) Gains | 1 | Insider Monkey | ||
| 13.04. | Oncology Institute reports $1.8M Medicare savings in latest period | 1 | Investing.com | ||
| ONCOLOGY INSTITUTE Aktie jetzt für 0€ handeln | |||||
| 13.04. | TOI Management, LLC: The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement | 4 | GlobeNewswire (USA) | ||
| 06.04. | TOI Management, LLC: The Oncology Institute Names Minh Merchant Chief Legal Officer | 1 | GlobeNewswire (USA) | ||
| 13.03. | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | 1 | Benzinga.com | ||
| 12.03. | Oncology Institute, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12.03. | Oncology Institute, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 23.02. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.01. | The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue | 1 | Seeking Alpha | ||
| 09.01. | TOI Management, LLC: The Oncology Institute Announces Leadership Promotions | 3 | GlobeNewswire (USA) | ||
| 07.01. | Oncology Institute, Inc. - 8-K, Current Report | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BILLIONTOONE | 99,65 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,690 | 0,00 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| ALIGNMENT HEALTHCARE | 20,225 | -0,07 % | Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock? | ||
| BRIGHTSPRING HEALTH SERVICES | 63,08 | 0,00 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| GENEDX | 60,99 | 0,00 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| PRIVIA HEALTH GROUP | 23,360 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LUMEXA IMAGING | 9,520 | 0,00 % | Lumexa Imaging Holdings, Inc.: Lumexa Imaging Announces First Quarter 2026 Results | RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,560 | +2,22 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 8,610 | 0,00 % | Goldman Sachs initiates Lifestance Health stock at neutral | ||
| ADAPTHEALTH | 10,100 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| PROGYNY | 25,640 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| HEARTFLOW | 30,670 | 0,00 % | Piper Sandler bestätigt Rating für Heartflow: Plaque-Umsätze sollen Wachstum antreiben | ||
| FRESENIUS | 37,950 | +1,88 % | FRESENIUS SE & CO KGAA - Stabilität mit Fokus auf Struktur | ||
| BETA BIONICS | 14,690 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,110 | +2,06 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |